SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTaylor Wimpey Regulatory News (TW.)

Share Price Information for Taylor Wimpey (TW.)

Share Price is delayed by 15 minutes
Get Live Data
77.04    2.24 (2.99%)
Bid:
77.02
Ask:
77.10
Spread: 0.08 (0.104%)
Market Cap: £2.68b
TW. Live PriceLast checked at - London Stock Exchange

Intraday Taylor Wimpey Share Chart

Trading Statement

16 Jan 2025 07:00

RNS Number : 5057T
Taylor Wimpey PLC
16 January 2025
Β 

Β 

Β 

16 January 2025

Taylor Wimpey plc

Trading statement for the year ended 31 December 2024

Taylor Wimpey is issuing the following update on trading ahead of its full year results for the year ended 31 December 2024, which will be announced on 27 February 2025.

Β 

Β 

Delivering in line with guidance

Β 

Jennie Daly, CEO, commented:

"We have delivered a good performance during 2024 with full year UK completions towards the upper end of our guidance range, as previously indicated, and operating profit expected to be in line with our previous guidance1. These results have been achieved while maintaining our high-quality build and customer service standards - with our customer service scores the highest they have ever been - testament to the hard work and commitment of our teams on the ground.

Taylor Wimpey is a strong and agile business with a clear strategy focused on operational excellence. While market conditions are uncertain, and we continue to monitor the impact of mortgage costs on affordability, we enter 2025 with a strong order book and land position, underpinned by a robust balance sheet and highly experienced teams, which positions us well to deliver volume growth in 2025.

We remain confident in the attractive medium and long term fundamentals of the sector and are well placed to play our part in addressing the significant undersupply of UK housing."

Β 

2024 performance

Total Group completions including joint ventures were 10,593 (2023: 10,848). UK home completions excluding joint ventures were 9,972 (2023: 10,356). We provided 2,178 affordable homes excluding joint ventures2 (2023: 2,351) equating to 22% of total UK completions(2023: 23%). Our UK net private reservation rate for 2024 was 0.75 homes per outlet per week (2023: 0.62). Excluding the impact of bulk deals, the net private sales rate was 0.67 (2023: 0.54). The cancellation rate for the full year was 15% (2023: 18%).

UK average selling price on private completions was Β£356k (2023: Β£370k) with the overall average selling price Β£319k (2023: Β£324k). We ended the year with a strong order book valued at Β£1,995 million (31 December 2023: Β£1,772 million), excluding joint ventures, which represents 7,312 homes (31 December 2023: 6,999 homes), of which 3,208 are private (2023: 2,565) and 4,104 are affordable (2023: 4,434). In the second half of the year, we experienced weaker pricing in the South of England where affordability has been most stretched, compared to the North where we have captured some price growth. As a result, underlying pricing in the order book is around 0.5% lower year on year.

In the UK, we traded from an average of 216 outlets in 2024 (2023: 238) and ended the year with a total of 213 outlets (31 December 2023: 237), slightly ahead of expectations due to a small number of delayed outlet closings.

We expect to deliver a c.19% gross margin for 2024, which includes a c.50 basis point benefit from previously reported land sales. We continue to expect full year Group operating profit* to be in line with previous guidance1.

Land and planning

As at 31 December 2024, our short term landbank stood at c.79k plots (2023: c.80k). Our strategic land pipeline was c.136k potential plots (2023: c.142k potential plots).

We approved c.12k plots (2023: c.3k) in 2024 which, as previously reported, partly reflects increased opportunities in the land market in the run up to the Budget.

A well-functioning planning system is key to achieving the Government's aims for growth in housebuilding. In December 2024, the Government revised the National Planning Policy Framework (NPPF) which we see as a positive step for the industry.

We have a high-quality, well-located landbank and our experienced teams continue to work hard to progress this land through planning. Whilst changes to the planning system are encouraging, we expect these to take time to impact land supply.

Spain current trading

Our Spanish business performed well, completing 504 homes in the year (2023: 410) at an average selling price of €440k (2023: €400k). The total order book as at 31 December 2024 stood at 491 homes (31 December 2023: 490 homes).

Group cash position

We ended the year with a net cash‑ position of Β£565 million (31 December 2023: Β£678 million net cash), ahead of our guidance as a result of the timing of land purchases.

Outlook

We begin the year with an increased order book compared to the start of 2024, thanks to stronger sales in the latter half of last year. We have seen an encouraging level of enquiries at the start of the year, however it is too early to gauge customer behaviour for 2025. Given our order book and current land position, we remain well placed to grow volumes in 2025, dependent on the evolution of mortgage rates and their impact on affordability.

Whilst price negotiations for 2025 are ongoing, we anticipate increased build cost pressure as a result of the changed economic backdrop, including as suppliers seek to factor in the impacts of the recent UK Budget.Β 

Looking forward, we maintain a strong balance sheet, have highly experienced teams and are well positioned to optimise our strong landbank and strategic pipeline for growth. We remain confident in the attractive medium and long term fundamentals of the sector and are well placed to play our part in addressing the significant undersupply of UK housing.

1 Previous guidance reflected Company compiled consensus published on 5 November 2024 with full year 2024 Group operating profit including joint ventures and excluding exceptional items of Β£416 million.

2 Full year 2024 affordable home completions including joint ventures were 2,199 (2023: 2,388).

* Operating profit is defined as profit on ordinary activities before financing, exceptional items, and tax, after share of results of joint ventures.

‑ Net cash is defined as total cash less total borrowings.

Β 

Β 

-Ends-

Β 

CEO Jennie Daly and Group Finance Director Chris Carney will be hosting a conference call with Q&A for analysts and investors at 9.00am on 16 January 2025. The call will be recorded and streamed live to our website: www.taylorwimpey.co.uk/corporate/investors/results-and-reports

For further information please contact:

Taylor Wimpey plc Tel: +44 (0) 1494 885656

Jennie Daly, CEO

Chris Carney, Group Finance Director

Debbie Archibald, Investor Relations

Andrew McGeary, Investor Relations

Β 

FGS Global TaylorWimpey@fgsglobal.com

Faeth Birch

Anjali Unnikrishnan

Β 

Notes to editors:

Taylor Wimpey plc is a customer-focused homebuilder, operating at a local level from 22 regional businesses across the UK. We also have operations in Spain.

For further information, please visit the Group's website: www.taylorwimpey.co.uk

Follow our company page on LinkedIn, Taylor Wimpey plc

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTFLFIALVIELIE
Date   Source Headline
11th Apr 20164:15 pmRNSDirector/PDMR Shareholding
1st Apr 20169:15 amRNSTotal Voting Rights
30th Mar 20166:01 pmRNSDirector/PDMR Shareholding
30th Mar 201610:58 amRNSDirector/PDMR Shareholding
24th Mar 20162:27 pmRNSDirector/PDMR Shareholding
18th Mar 20161:16 pmRNSAnnual Financial Report
15th Mar 201610:58 amRNSHolding(s) in Company
11th Mar 20169:51 amRNSHolding(s) in Company
9th Mar 20163:10 pmRNSDirector/PDMR Shareholding
7th Mar 20164:18 pmRNSDirector/PDMR Shareholding
2nd Mar 20164:22 pmRNSDirector/PDMR Shareholding
1st Mar 20162:23 pmRNSTotal Voting Rights
1st Mar 20167:00 amRNSFull Year Results
19th Feb 20169:10 amRNSHolding(s) in Company
10th Feb 201611:25 amRNSDirector/PDMR Shareholding
1st Feb 201611:54 amRNSTotal Voting Rights
11th Jan 201611:35 amRNSDirector/PDMR Shareholding
11th Jan 20167:00 amRNSTrading statement for the year ended 31 Dec 2015
4th Jan 20163:12 pmRNSBlocklisting Interim Review
4th Jan 20163:10 pmRNSBlocklisting Interim Review
4th Jan 20163:04 pmRNSTotal Voting Rights
18th Dec 201512:47 pmRNSDirector/PDMR Shareholding
18th Dec 201510:08 amRNSBlock Listing Application
14th Dec 201510:05 amRNSHolding(s) in Company
10th Dec 201512:15 pmRNSDirector/PDMR Shareholding
9th Dec 20157:00 amRNSDirectorate Change
1st Dec 20159:30 amRNSTotal Voting Rights
23rd Nov 20157:55 amRNSAmendment to earlier Block Listing Application
16th Nov 20157:00 amRNSTrading Statement
12th Nov 201511:47 amRNSDirector/PDMR Shareholding
5th Nov 201512:18 pmRNSAdditional Listing
2nd Nov 201510:06 amRNSTotal Voting Rights
12th Oct 20152:07 pmRNSDirector/PDMR Shareholding
12th Oct 201511:43 amRNSDirector/PDMR Shareholding
1st Oct 20159:00 amRNSTotal Voting Rights
10th Sep 201510:36 amRNSDirector/PDMR Shareholding
1st Sep 20159:19 amRNSTotal Voting Rights
26th Aug 201511:01 amRNSHolding(s) in Company
14th Aug 20158:48 amRNSHolding(s) in Company
11th Aug 20153:18 pmRNSHolding(s) in Company
11th Aug 20153:15 pmRNSDirector/PDMR Shareholding
31st Jul 201511:28 amRNSHolding(s) in Company
29th Jul 20157:01 amRNSHalf Yearly Results
21st Jul 20154:03 pmRNSHolding(s) in Company
10th Jul 20158:07 amRNSDirector/PDMR Shareholding
9th Jul 201511:52 amRNSDirector/PDMR Shareholding
1st Jul 20159:30 amRNSBlocklisting Interim Review
1st Jul 20159:00 amRNSTotal Voting Rights
19th Jun 201510:10 amRNSHolding(s) in Company
9th Jun 20152:58 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.